Russell Investments Group, Ltd. - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 24 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q3 2021$13,000
-13.3%
5,1980.0%0.00%
Q2 2021$15,000
-6.2%
5,1980.0%0.00%
Q1 2021$16,000
+6.7%
5,1980.0%0.00%
Q4 2020$15,000
-6.2%
5,1980.0%0.00%
Q3 2020$16,0000.0%5,1980.0%0.00%
Q2 2020$16,000
-11.1%
5,1980.0%0.00%
Q1 2020$18,000
-25.0%
5,1980.0%0.00%
Q4 2019$24,000
-17.2%
5,1980.0%0.00%
Q3 2019$29,000
-12.1%
5,1980.0%0.00%
Q2 2019$33,000
+6.5%
5,1980.0%0.00%
Q1 2019$31,0000.0%5,1980.0%0.00%
Q4 2018$31,000
+3.3%
5,1980.0%0.00%
Q3 2018$30,000
-6.2%
5,1980.0%0.00%
Q2 2018$32,000
-8.6%
5,1980.0%0.00%
Q1 2018$35,000
-7.9%
5,1980.0%0.00%
Q4 2017$38,000
+2.7%
5,1980.0%0.00%
Q3 2017$37,0000.0%5,1980.0%0.00%
Q2 2017$37,000
+2.8%
5,1980.0%0.00%
Q1 2017$36,000
+24.1%
5,1980.0%0.00%
Q4 2016$29,0005,1980.00%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q3 2021
NameSharesValueWeighting ↓
Sterling Financial Planning, Inc. 22,031$46,0000.03%
BERKSHIRE ASSET MANAGEMENT LLC/PA 189,048$392,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 286,655$595,0000.01%
Renaissance Technologies 622,228$1,291,0000.00%
ACADIAN ASSET MANAGEMENT LLC 188,164$390,0000.00%
Oakworth Capital, Inc. 3,052$6,0000.00%
BlackRock Inc. 140,248$292,0000.00%
Citadel Advisors 32,300$67,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 28,900$60,0000.00%
TWO SIGMA ADVISERS, LP 34,592$72,0000.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders